Scott D. Grimes - 18 Nov 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
18 Nov 2021
Net transactions value
-$470,770
Form type
4
Filing time
22 Nov 2021, 16:23:00 UTC
Previous filing
17 Nov 2021
Next filing
06 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $82,826 -1,102 -0.45% $75.16 245,857 18 Nov 2021 Direct F1, F2
transaction CDLX Common Stock Sale $66,222 -871 -0.35% $76.03 244,986 18 Nov 2021 Direct F1, F3
transaction CDLX Common Stock Sale $38,635 -500 -0.2% $77.27 244,486 18 Nov 2021 Direct F1, F4
transaction CDLX Common Stock Sale $48,422 -617 -0.25% $78.48 243,869 18 Nov 2021 Direct F1, F5
transaction CDLX Common Stock Sale $151,772 -1,900 -0.78% $79.88 241,969 18 Nov 2021 Direct F1, F6
transaction CDLX Common Stock Sale $25,101 -310 -0.13% $80.97 241,659 18 Nov 2021 Direct F1, F7
transaction CDLX Common Stock Sale $41,170 -500 -0.21% $82.34* 241,159 18 Nov 2021 Direct F1, F8
transaction CDLX Common Stock Sale $16,622 -200 -0.08% $83.11* 240,959 18 Nov 2021 Direct F1, F9
holding CDLX Common Stock 57,112 18 Nov 2021 See Footnote F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended June 15, 2021.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $74.73 to $75.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.74 to $76.69, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.82 to $77.68, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.87, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.47 to $80.46, inclusive.
F7 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $80.69 to $81.38, inclusive.
F8 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.75 to $82.58, inclusive.
F9 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $82.76 to $83.45, inclusive.
F10 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.